The Pros and Cons of the QALY: An AJMC Podcast with Jennifer Bright and Lou Garrison
After the panel presentation, “The Controversial QALY: Is There a Middle Ground in the Debate?” was wrapped up at ISPOR, AJMC deputy editor, Jaime Rosenberg, sat down with IVI's Jennifer Bright and Lou Garrison (assistant [...]
IVI Moderated ISPOR Panel: The Controversial QALY
IVI Executive Director, Jennifer Bright, moderated a fascinating panel discussion on the quality-adjusted life-year (QALY) and whether there is room for a middle ground in the discussion about its merits and shortcomings. Lou Garrison, PhD, [...]
PRESS RELEASE: IVI Launches New Research Brief Series “Value Blueprints”
IVI launches a new research brief series to present research findings and method insights from the OSVP. Let’s sparks a conversation into next-gen value assessment. Read the full press release here.
IVI Announces a Request for Proposal (RFP)
IVI is committed to exploring scientifically rigorous methods that improve the practice of value assessment in a collaborative, iterative environment. To that end, we are pleased to announce the call for research proposals that help [...]
IVI’s Jeroen Jensen and Devin Incerti write in the Journal of Managed Care and Specialty Pharmacy
IVI's Lead Scientific Advisor and Lead Economist for the Open-Source Value Platform (OSVP), Jeroen Jansen and Devin Incerti, respectively, collaborate with Jeffery Curtis in a recent article published in the Journal of Managed Care and [...]
Jennifer Bright Addresses Differences Between Consumer-Driven and Patient-Centered Healthcare
IVI Executive Director, Jennifer Bright, writes in Morning Consult about the differences between patient-centered and consumer-driven healthcare. Read the full article here.
“Good Enough” Doesn’t Cut it in Value Assessment
IVI’s Jennifer Bright and Mark Linthicum write in STAT News that we’re squandering time and resources trying to find a neat answer to “what is value?” by focusing on the cost of drugs without tackling [...]
Steps Employers at the Crossroads of Healthcare Costs and Value Should Consider
IVI’s Jennifer Bright the president of the Institute for Integrated Benefits, Tom Parry, Ph.D., write in Fierce Healthcare that most employers have no idea how their benefit programs affect employee health outcomes. They outline a [...]
Crowdsourcing for Value in Healthcare
Value-based healthcare is predicated on collaboration. Sharing of data, methods, pathways and perspectives among different stakeholders is paramount if the transition to value-based care is to be fully realized. Instead of relying solely on legacy [...]
Watch Mark Linthicum’s “101 Course” on IVI’s New Non-Small Cell Lung Cancer Value Model
IVI's Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI's open-source model for assessing value in non-small cell lung cancer therapies. If you want to [...]
IVI to Hold Two Public Webinars on New Open-Source Model for Non-Small Cell Lung Cancer
IVI will host two upcoming webinars focused on its new disease-specific, open-source value model to assess EGFR+ non-small cell lung cancer (NSCLC) therapy sequences. These webinars are free and open to the public. We hope [...]
PRESS RELEASE: IVI Unveils New Value Assessment Model for Non-Small Cell Lung Cancer
IVI released our initial version of the new Open-Source Value Platform (OSVP) model for non-small cell lung cancer. Specifically, the model provides information on the relative value of sequential treatments for epidermal growth factor receptor [...]